JPRN-UMIN000021668已完成未知
Safety and efficacy of intra-procedural landiolol, a very short acting beta-1 adrenergic receptor blocker, in primary percutaneous coronary intervention for acute myocardial infarction - Safety and efficacy of landiolol in primary percutaneous coronary intervention for acute myocardial infarction
Yokohama City University Graduate School of Medicine Cardiorenal science0 个研究点目标入组 55 人开始时间: 2016年3月29日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 55
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •HR<50bpm Killip>2 History of myocardial infarction 2or3 AV block B blocker before admission History of asthma
研究者
相似试验
已完成
不适用
Evaluation of perioperative landiolol administration for preventing atrial fibrillation during esophagectomy.Esophageal cancer(Esophagectomy)JPRN-UMIN000024040Shizuoka General Hospital188
已完成
不适用
A study of efficacy and safety of landiolol hydrochloride for pulmonary resectioJPRN-UMIN000029348ippon Medical School Hospital64
已完成
4 期
Clinical study of Landiolol hydrochloride in the treatment of postoperative atrial fibrillation/atrial flutter after cardiovascular surgerytachyarrhythmiaJPRN-UMIN000000957JL-Knight Study Group400
招募中
不适用
Perioperative landiolol hydrochloride for preventing of atrial fibrillation after lung resectiolung cancerJPRN-UMIN000007561ippon Medical School Department of Anesthesiolgy100
已完成
4 期
Evaluation of the preventive effect of landiolol on postoperative atrial fibrillatioPostoperative atrial fibrillationJPRN-UMIN000003378Department of Cardiovascular Sugery,Tohoku University Hospital150